Maccura Biotechnology Co.Ltd
300463.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.79B
Close$
$-0.37
104% downside
Current Fair Value
104% downsideOvervalued by 104% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.79 Billion |
|---|---|
| Enterprise Value | $6.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.9 |
| Outstanding Shares | 604,666,624 |
Return
| Return on Equity | -0.56% |
|---|---|
| Return on Assets | -0.46% |
| Return on Invested Capital | -1.32% |
Valuation & Multiples
| P/E Ratio | -164.32 |
|---|---|
| PEG | -108.73 |
| Price to Sales | 3.07 |
| Price to Book Ratio | 0.92 |
| Enterprise Value to Revenue | 2.86 |
| Enterprise Value to EBIT | -65.46 |
| Enterprise Value to Net Income | -171 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.42
Average shareholder expectationRevenue Estimate
$558.76 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.42
Average shareholder expectationRevenue Estimate
$537.87 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Maccura Biotechnology Co.Ltd
2,875 employees
CEO: Wu Mingjian Maccura Biotechnology Co. Ltd. is an enterprise actively involved in the entire process of in vitro diagnostic (IVD) products, from their initial conceptualization and refinement (research and development) to mass production and market d...